<DOC>
	<DOCNO>NCT00252278</DOCNO>
	<brief_summary>Children adolescent Attention-Deficit/Hyperactivity Disorder ( ADHD ) commonly experience difficulty initiate maintain sleep . Studies show daytime sleepiness result insufficient sleep affect attention learning . Therefore , treat insomnia child ADHD may improve sleep , could potentially improve ADHD symptom well . The main purpose study examine effect atomoxetine ADHD-related insomnia . Atomoxetine ( StratteraÂ® ) non-stimulant drug use treat ADHD symptoms child adult , evidence may also positive effect sleep child ADHD . During study , participant receive either atomoxetine placebo period four week . We expect effect atomoxetine sleep differ placebo , atomoxetine great effect improve sleep difficulty .</brief_summary>
	<brief_title>Effect Atomoxetine ADHD-Related Insomnia Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Boy girl age 617 year , inclusive , Englishspeaking Meet DSMIV criterion AttentionDeficit/Hyperactivity Disorder Have sleep initiation define : 1. difficulty initiate maintain sleep view problem child caregiver 2. sleep onset delay exclusively related direct rebound effect psychostimulant treatment Have parent legal guardian willing participate study Have primary sleep disorder ( ) ( e.g . obstructive sleep apnea periodic limb movement disorder ) Have history significant chronic medical ( e.g . diabetes , severe asthma ) psychiatric ( e.g . depression ) illness Have history chronic use sedating ( e.g . antihistamine ) alertness enhance ( e.g . caffeine ) medication Have history failure respond adequate ( defined appropriate dose adequate duration therapy ) previous trial atomoxetine</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>